Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10064060 | 0.92 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL28318815 | 0.81 | ALDH1A1 (0.93) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL244871 | 0.81 | ALDH1A1 (0.73) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL15617 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL5098181 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL2048901 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL5098171 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| Oxirane SCHEMBL7257162 | 0.79 | ALDH1A1 (0.89) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL11746808 | 0.79 | ALDH1A1 (0.75) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 | |
| SCHEMBL9610619 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBCYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9645498-B2 | Developer and patterning process using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-09 | — | — | US | disclosed |
| US-9645498-B2 | Developer and patterning process using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-09 | — | — | US | disclosed |
| US-20160195813-A1 | DEVELOPER AND PATTERNING PROCESS USING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160195813-A1 | DEVELOPER AND PATTERNING PROCESS USING THE SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-8623590-B2 | Pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-8623590-B2 | Pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20120108043-A1 | PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120108043-A1 | PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160195813-A1 | DEVELOPER AND PATTERNING PROCESS USING THE SAME | BMPR1A, RER1, BMPR1B | ALDH1A1 1508/4885TSHR 3188/4885THRB 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.